Michael Fischereder

Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation

Bernd Krüger, Stefanie Krick, Navdeep Dhillon et al. · Proceedings of the National Academy of Sciences · 2009 · 339 citations · Full text

The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable

Ute Hoffmann, Michael Fischereder, Bernd KruCombining Diaeresisger et al. · Journal of the American Society of Nephrology · 2004 · 320 citations

CC chemokine receptor 5 and renal-transplant survival

Michael Fischereder, Bruno Luckow, Berthold Hocher et al. · The Lancet · 2001 · 290 citations

Transplantation, Kidney Transplant, Immunology +4

Effects of Donor Pretreatment With Dopamine on Graft Function After Kidney Transplantation

Peter Schnuelle, Uwe Göttmann, Simone Hoeger et al. · JAMA · 2009 · 259 citations

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 203 citations · Full text